CD4 +FoxP3 + regulatory T cells from Gαi2 -/- mice are functionally active in vitro, but do not prevent colitis

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Götlind, Yu Yuan C ^a   Raghavan, Sukanya ^a   Bland, Paul W ^a,b   Hörnquist, Elisabeth Hultgren ^c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c ÖREBRO UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; INTERLEUKIN 4; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; GNAI2 PROTEIN, MOUSE; HERMES ANTIGEN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; L SELECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4 CD8 RATIO; CD4+ CD25+ T LYMPHOCYTE; CELL DIVISION; COCULTURE; COLITIS; COLONIC LYMPHOID PATCHES; CONTROLLED STUDY; CYTOKINE RELEASE; EFFECTOR CELL; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LAMINA PROPRIA; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; SPLEEN; ANIMAL; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL FRACTIONATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; INTESTINE MUCOSA; MALE; METABOLISM; METHODOLOGY; PATHOLOGY;

ERAGROSTIS TEF; MUS;

ANIMALS; ANTIGENS, CD44; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; COCULTURE TECHNIQUES; COLITIS; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GTP-BINDING PROTEIN ALPHA SUBUNIT, GI2; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; L-SELECTIN; MALE; MICE; SPLEEN; SUBCELLULAR FRACTIONS; T-LYMPHOCYTES, REGULATORY;

EID: 80053062763     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025073     Document Type: Article

References (39)

1. Hornquist CE, Lu X, Rogers-Fani PM, Rudolph U, Shappell S, et al. (1997) G(alpha)i2-deficient mice with colitis exhibit a local increase in memory CD4+ T cells and proinflammatory Th1-type cytokines. J Immunol 158: 1068-1077.
2. Ohman L, Franzen L, Rudolph U, Birnbaumer L, Hornquist EH, (2002) Regression of Peyer's patches in G alpha i2 deficient mice prior to colitis is associated with reduced expression of Bcl-2 and increased apoptosis. Gut 51: 392-397.
3. Ohman L, Franzen L, Rudolph U, Harriman GR, Hultgren Hornquist E, (2000) Immune activation in the intestinal mucosa before the onset of colitis in Galphai2-deficient mice. Scand J Immunol 52: 80-90.
4. Dalwadi H, Wei B, Schrage M, Spicher K, Su TT, et al. (2003) B cell developmental requirement for the G alpha i2 gene. J Immunol 170: 1707-1715.
5. Saha C, Nigam SK, Denker BM, (1998) Involvement of Galphai2 in the maintenance and biogenesis of epithelial cell tight junctions. J Biol Chem 273: 21629-21633.
6. He J, Gurunathan S, Iwasaki A, Ash-Shaheed B, Kelsall BL, (2000) Primary role for Gi protein signaling in the regulation of interleukin 12 production and the induction of T helper cell type 1 responses. J Exp Med 191: 1605-1610.
7. Elgbratt K, Bjursten M, Willen R, Bland PW, Hornquist EH, (2007) Aberrant T-cell ontogeny and defective thymocyte and colonic T-cell chemotactic migration in colitis-prone Galphai2-deficient mice. Immunology 122: 199-209.
8. Huang TT, Zong Y, Dalwadi H, Chung C, Miceli MC, et al. (2003) TCR-mediated hyper-responsiveness of autoimmune Galphai2(-/-) mice is an intrinsic naive CD4(+) T cell disorder selective for the Galphai2 subunit. Int Immunol 15: 1359-1367.
9. Hultgren OH, Berglund M, Bjursten M, Hultgren Hornquist E, (2006) Serum interleukin-1 receptor antagonist is an early indicator of colitis onset in Galphai2-deficient mice. World J Gastroenterol 12: 621-624.
10. Faria AM, Weiner HL, (2005) Oral tolerance. Immunol Rev 206: 232-259.
11. Mackay IR, (2000) Science, medicine, and the future: Tolerance and autoimmunity. BMJ 321: 93-96.
12. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, et al. (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742.
13. Weiner HL, (2001) Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 182: 207-214.
14. Vignali DA, Collison LW, Workman CJ, (2008) How regulatory T cells work. Nat Rev Immunol 8: 523-532.
15. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, (2009) Regulatory T cells: how do they suppress immune responses? Int Immunol 21: 1105-1111.
16. Khattri R, Cox T, Yasayko SA, Ramsdell F, (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4: 337-342.
17. Hori S, Nomura T, Sakaguchi S, (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
18. Fontenot JD, Gavin MA, Rudensky AY, (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4: 330-336.
19. Gambineri E, Torgerson TR, Ochs HD, (2003) Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 15: 430-435.
20. Singh B, Read S, Asseman C, Malmstrom V, Mottet C, et al. (2001) Control of intestinal inflammation by regulatory T cells. Immunol Rev 182: 190-200.
21. Izcue A, Coombes JL, Powrie F, (2009) Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol 27: 313-338.
22. Larsson AE, Melgar S, Rehnstrom E, Michaelsson E, Svensson L, et al. (2006) Magnetic resonance imaging of experimental mouse colitis and association with inflammatory activity. Inflamm Bowel Dis 12: 478-485.
23. Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, et al. (2003) CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 197: 111-119.
24. Zhang Y, Finegold MJ, Jin Y, Wu MX, (2005) Accelerated transition from the double-positive to single-positive thymocytes in G alpha i2-deficient mice. Int Immunol 17: 233-243.
25. Cepek KL, Shaw SK, Parker CM, Russell GJ, Morrow JS, et al. (1994) Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature 372: 190-193.
26. Karecla PI, Bowden SJ, Green SJ, Kilshaw PJ, (1995) Recognition of E-cadherin on epithelial cells by the mucosal T cell integrin alpha M290 beta 7 (alpha E beta 7). Eur J Immunol 25: 852-856.
27. Simonetta F, Chiali A, Cordier C, Urrutia A, Girault I, et al. (2010) Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells. Eur J Immunol 40: 2528-2538.
28. Thornton AM, Donovan EE, Piccirillo CA, Shevach EM, (2004) Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J Immunol 172: 6519-6523.
29. Leipe J, Skapenko A, Lipsky PE, Schulze-Koops H, (2005) Regulatory T cells in rheumatoid arthritis. Arthritis Res Ther 7: 93.
30. Leithauser F, Meinhardt-Krajina T, Fink K, Wotschke B, Moller P, et al. (2006) Foxp3-expressing CD103+ regulatory T cells accumulate in dendritic cell aggregates of the colonic mucosa in murine transfer colitis. Am J Pathol 168: 1898-1909.
31. Holtta V KP, Sipponen T, Westerholm-Ormio M, Kociubinski G, Salo H, et al. (2008) IL-23/IL-17 immunity as a hallmark of Crohn's disease. Inflamm Bowel Dis 14: 1175-1184.
32. Maul J, Loddenkemper C, Mundt P, Berg E, Giese T, et al. (2005) Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 128: 1868-1878.
33. Lehmann J, Huehn J, de la Rosa M, Maszyna F, Kretschmer U, et al. (2002) Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells. Proc Natl Acad Sci U S A 99: 13031-13036.
34. Bluestone JA, Tang Q, (2005) How do CD4+CD25+ regulatory T cells control autoimmunity? Curr Opin Immunol 17: 638-642.
35. Goodman WA, Levine AD, Massari JV, Sugiyama H, McCormick TS, et al. (2009) IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J Immunol 183: 3170-3176.
36. Pasare C, Medzhitov R, (2003) Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
37. Yamamoto M, Yoshizaki K, Kishimoto T, Ito H, (2000) IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol 164: 4878-4882.
38. Suzuki A, Hanada T, Mitsuyama K, Yoshida T, Kamizono S, et al. (2001) CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J Exp Med 193: 471-481.
39. Hill JA, Hall JA, Sun CM, Cai Q, Ghyselinck N, et al. (2008) Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells. Immunity 29: 758-770.